Author pages are created from data sourced from our academic publisher partnerships and public sources.
Assessment of determinants for osteoporosis in elderly men
SummaryThe aim of this cross-sectional study was to determine and quantify some determinants associated to low bone mineral density (BMD) in elderly men. This study showed that ageing, a lower body… Expand
Impact of chondroitin sulphate on health utility in patients with knee osteoarthritis: towards economic analysis
- O. Bruyère, S. Scholtissen, A. Neuprez, M. Hiligsmann, A. Toukouki, J. Reginster
- Journal of medical economics
- 1 December 2009
Abstract Objectives: The first objective was to assess the effect of the chondroitin 4 and 6 sulphate (CS) on health-related quality of life using utility values in patients with knee osteoarthritis… Expand
Strontium ranelate: The first agent of a new therapeutic class in osteoporosis
- A. Neuprez, M. Hiligsmann, S. Scholtissen, O. Bruyère, J. Reginster
- Advances in therapy
- 6 December 2008
Strontium ranelate is a new agent developed for the management of post-menopausal osteoporosis. It has a unique mode of action, based on an uncoupling between bone formation (increased) and bone… Expand
Glucosamine sulphate in the treatment of knee osteoarthritis: cost‐effectiveness comparison with paracetamol
- S. Scholtissen, O. Bruyère, +5 authors J. Reginster
- International journal of clinical practice
- 1 May 2010
Introduction: The aim of this study was to explore the cost‐effectiveness of glucosamine sulphate (GS) compared with paracetamol and placebo (PBO) in the treatment of knee osteoarthritis. For this… Expand
Cost-effectiveness of glucosamine sulfate compared to acetaminophen in the treatment of knee osteoarthrits: a French health care perspective
Assessement of risk factors for osteoporotic fractures in elderly men
Glucosamine sulfate in the treatment of knee osteoarthritis: impact on health utility.
Effect of glucosamine sulfate on health utility data in patients with knee osteoarthritis : reanalysis of two 3-year prospective studies.
Analyses coût-efficacité du sulfate de glucosamine chez des patients gonarthrosiques : comparaison avec le paracétamol.